FDA recall D-0160-2023

Product

Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 Capsules per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 0527-1632-10

Reason for recall

Failed Impurity/Degradation Specifications

Distribution

Nationwide USA

Key facts

Status

Terminated

Initiation date

2022-11-09

Report date

2023-01-25

Termination date

2023-06-08

Voluntary/Mandated

Voluntary: Firm initiated

Location

Seymour, IN, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0160-2023